Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)

NCT03530345 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT03530345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03530345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Lead sponsor
Grünenthal GmbH
Phase
Phase 3
Overall status
Terminated
Start date
May 30, 2018
Completion date
July 31, 2019
Enrollment
182 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

complex regional pain syndrome (crps)